Induction of tumours in mice and rats with ferric sodium gluconate and iron dextran glycerol glycoside.
作者信息
Carter R L, Mitchley B C, Roe F J
出版信息
Br J Cancer. 1968 Sep;22(3):521-6. doi: 10.1038/bjc.1968.62.
Abstract
摘要
相似文献
1
Induction of tumours in mice and rats with ferric sodium gluconate and iron dextran glycerol glycoside.用葡萄糖酸铁钠和葡聚糖甘油糖苷铁在小鼠和大鼠中诱导肿瘤。
Br J Cancer. 1968 Sep;22(3):521-6. doi: 10.1038/bjc.1968.62.
2
3
Early development of injection-site sarcomas in rats: a study of tumours induced by iron-dextran.大鼠注射部位肉瘤的早期发展：右旋糖酐铁诱导肿瘤的研究
Br J Cancer. 1969 Sep;23(3):559-66. doi: 10.1038/bjc.1969.69.
4
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.血液透析患者静脉注射右旋糖酐铁、葡萄糖酸铁钠和蔗糖铁后氧化应激标志物的比较。
Pharmacotherapy. 2007 Mar;27(3):343-50. doi: 10.1592/phco.27.3.343.
5
Oncological study in rats of Ferastral, an iron-poly-(sorbitol-gluconic acid) complex, after intramuscular administration.对铁-聚（山梨醇-葡萄糖酸）复合物Ferastral进行肌肉注射后在大鼠身上开展的肿瘤学研究。
Scand J Haematol Suppl. 1977;32:87-98. doi: 10.1111/j.1600-0609.1977.tb01220.x.
6
Comparison of the oncogenicities of four structurally isomeric N-hydroxyxanthines.四种结构异构的N-羟基黄嘌呤致癌性的比较。
Cancer Res. 1978 Jul;38(7):2038-42.
7
Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy.胃肠外铁剂治疗会导致血浆、正常肾脏以及实验性肾病中单核细胞趋化蛋白-1（MCP-1）的蓄积。
Kidney Int. 2005 Oct;68(4):1533-42. doi: 10.1111/j.1523-1755.2005.00565.x.
8
[THE EFFECT OF IRON INJECTIONS IN ANIMAL EXPERIMENTS].
Arzneimittelforschung. 1963 Nov;13:939-45.
9
Do we need to change our administration practice with regard to sodium ferric gluconate complex in glucose?我们是否需要改变关于葡萄糖酸铁钠复合物在葡萄糖中的给药方式？
Nephrol Dial Transplant. 2005 Jun;20(6):1279. doi: 10.1093/ndt/gfh552. Epub 2005 Mar 29.
10
引用本文的文献
1
The Intrinsic Biological Identities of Iron Oxide Nanoparticles and Their Coatings: Unexplored Territory for Combinatorial Therapies.氧化铁纳米颗粒及其涂层的内在生物学特性：组合疗法的未知领域。
Nanomaterials (Basel). 2020 Apr 27;10(5):837. doi: 10.3390/nano10050837.
2
Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.猫注射部位肉瘤的起源：慢性炎症的可能作用——综述
ISRN Vet Sci. 2011 Apr 12;2011:210982. doi: 10.5402/2011/210982. Print 2011.
3
Sarcoma after intramuscular iron injection.肌肉注射铁剂后发生的肉瘤。
Br Med J. 1973 Jun 16;2(5867):667. doi: 10.1136/bmj.2.5867.667.
4
Sarcoma after injection of intramuscular iron.肌肉注射铁剂后发生的肉瘤。
Br Med J. 1973 May 5;2(5861):277-9. doi: 10.1136/bmj.2.5861.277.
5
Intramuscular injections of iron compounds and oncogenesis in man.人体肌肉注射铁化合物与肿瘤发生
Br Med J. 1978 Mar 18;1(6114):683-5. doi: 10.1136/bmj.1.6114.683.
本文引用的文献
1
The carcinogenic action of complex iron preparations.复合铁制剂的致癌作用。
Br J Cancer. 1961 Dec;15(4):838-47. doi: 10.1038/bjc.1961.97.
2
IRON-DEXTRAN CARCINOGENESIS IN RATS: EFFECT OF DISTRIBUTING INJECTED MATERIAL BETWEEN ONE, TWO, FOUR, OR SIX SITES.右旋糖酐铁在大鼠体内的致癌作用：将注射材料分别注射到一个、两个、四个或六个部位的影响。
Br J Cancer. 1964 Dec;18(4):801-8. doi: 10.1038/bjc.1964.93.
3
INDUCTION OF SARCOMATA IN RABBITS BY INTRAMUSCULAR INJECTION OF IRON-DEXTRAN ("IMFERON").肌肉注射右旋糖酐铁（“右旋糖酐铁注射液”）诱导家兔肉瘤形成
Br Med J. 1964 Jun 20;1(5398):1593-4. doi: 10.1136/bmj.1.5398.1588.
4
Sarcoma induction by iron-carbohydrate complexes.铁-碳水化合物复合物诱导肉瘤
Br Med J. 1962 Jun 30;1(5295):1800-3. doi: 10.1136/bmj.1.5295.1800.
5
On the carcinogenicity of an iron-dextran complex.关于右旋糖酐铁复合物的致癌性
J Natl Cancer Inst. 1960 Jan;24:109-47.
6
Iron overloading phenomena in animals.
Toxicol Appl Pharmacol. 1960 Nov;2:683-707. doi: 10.1016/0041-008x(60)90086-7.
7
Induction of sarcoma in the rat by iron-dextran complex.右旋糖酐铁复合物诱导大鼠肉瘤
Br Med J. 1959 Apr 11;1(5127):947-9. doi: 10.1136/bmj.1.5127.947.
8
Iron-dextran carcinogenesis in rats: influence of dose on the number and types of neoplasm induced.大鼠右旋糖酐铁致癌作用：剂量对诱发肿瘤数量和类型的影响。
Int J Cancer. 1967 Jul 15;2(4):370-80. doi: 10.1002/ijc.2910020412.
Zotero 插件